© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
August 09, 2022
The latest guidance for when to administer the COVID-19 vaccine to patients aged 6 months and older.
July 21, 2022
Adults aged 18 and older are eligible to receive the vaccine.
July 18, 2022
Groups responded quickly in defense of pharmacists’ ability to prescribe Paxlovid through Test to Treat programs.
July 07, 2022
The risk of breakthrough was higher in people living with HIV regardless of CD4 count or HIV viral suppression, according to findings reported by researchers at Johns Hopkins.
July 06, 2022
According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.
July 05, 2022
Purchase follows FDA recommendation to include Omicron component in boosters.
June 30, 2022
Epic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is open question.
June 21, 2022
Recent research has shown less than 1% of patients at high risk for experiencing severe COVID-19 who were treated with Paxlovid (nirmatrelvir and ritonavir) experienced a second bout of COVID-19.
June 17, 2022
Monoclonal antibodies have been helpful in preventing severe illness in patients at increased risk, but barriers to receiving this therapy exist.
June 15, 2022
A majority of survey respondents were willing to receive a COVID-19 vaccine.